Bococizumab is a novel anti-PCSK9 antibody specifically developed to treat hypercholesterolemia. It therapeutic agent functions through the PCSK9 protein, a critical regulator of cholesterol concentrations. By blocking https://zakariacvps166737.pointblog.net/bococizumab-a-novel-anti-pcsk9-antibody-for-hypercholesterolemia-91778425